X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AANJANEYA LIFECARE with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. DATSONS LABS   ACTAVIS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ACTAVIS
Dec-14
DR. DATSONS LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs12619,794-   
Low Rs3112,074-   
Sales per share (Unadj.) Rs133.03,564.4-  
Earnings per share (Unadj.) Rs0.2-444.8-  
Cash flow per share (Unadj.) Rs6.6327.0-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.87,731.1-  
Shares outstanding (eoy) m31.66265.90-   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.5 13.2%   
Avg P/E ratio x516.1-35.8 -1,440.8%  
P/CF ratio (eoy) x11.848.7 24.3%  
Price / Book Value ratio x0.62.1 29.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4774,236,897 0.1%   
No. of employees `000NA21.6 0.0%   
Total wages/salary Rs m560-   
Avg. sales/employee Rs ThNM43,878.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-5,475.6-  
INCOME DATA
Net Sales Rs m4,211947,779 0.4%  
Other income Rs m79-2,365 -3.3%   
Total revenues Rs m4,289945,413 0.5%   
Gross profit Rs m569121,756 0.5%  
Depreciation Rs m204205,229 0.1%   
Interest Rs m43029,895 1.4%   
Profit before tax Rs m13-115,733 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-8,490 0.0%   
Tax Rs m6-5,950 -0.1%   
Profit after tax Rs m5-118,273 -0.0%  
Gross profit margin %13.512.8 105.1%  
Effective tax rate %48.05.1 934.3%   
Net profit margin %0.1-12.5 -0.9%  
BALANCE SHEET DATA
Current assets Rs m6,852499,358 1.4%   
Current liabilities Rs m6,711364,179 1.8%   
Net working cap to sales %3.314.3 23.5%  
Current ratio x1.01.4 74.5%  
Inventory Days Days16158 277.2%  
Debtors Days Days31866 480.5%  
Net fixed assets Rs m3,673115,733 3.2%   
Share capital Rs m3170-   
"Free" reserves Rs m3,7610-   
Net worth Rs m4,0782,055,697 0.2%   
Long term debt Rs m1,6711,077,226 0.2%   
Total assets Rs m12,6333,767,417 0.3%  
Interest coverage x1.0-2.9 -35.9%   
Debt to equity ratio x0.40.5 78.2%  
Sales to assets ratio x0.30.3 132.5%   
Return on assets %3.4-2.3 -146.8%  
Return on equity %0.1-5.8 -2.0%  
Return on capital %7.7-3.0 -254.9%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Net fx Rs m3570-   
CASH FLOW
From Operations Rs m1,345162,752 0.8%  
From Investments Rs m-2,256-389,691 0.6%  
From Financial Activity Rs m-1,200218,950 -0.5%  
Net Cashflow Rs m-2,111-7,989 26.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.56 Rs / USD

Compare DR. DATSONS LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DR. DATSONS LABS With: IPCA LABS  DIVIS LABORATORIES  ALEMBIC PHARMA  GLENMARK PHARMA  NATCO PHARMA  



Today's Market

Sensex Ends 331 Points Higher; Oil & Gas Stocks Witness Buying(Closing)

After opening on a negative note, share markets in India witnessed buying interest during closing hours and ended the day on a positive note.

Related Views On News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

3 Big Money Makers to Round Out Your 2018 Portfolio(Profit Hunter)

Oct 31, 2018

The market is offering many strong opportunities in the small cap space right now. Don't miss out. This is the time to get rich.

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS